Anna is former CEO of Zelmic and Pharmiva. Since the start of Pharmiva in 2015, Anna has been managing and developing the company, from the early stages in product development to its present state of market readiness.
She has over 25 years of experience from managing research and development projects at MIP Technologies, Malmö University, Astra Zeneca, Pharmiva and Zelmic.
In addition to leading operational roles, Anna has also gained experience from board assignments in life science companies and the Danish-Swedish life science cluster organisation Medicon Valley Alliance.
Anna Holmberg holds a M.Sc. in Organic Chemistry and PhD in Physical Chemistry from Lund University